BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8584455)

  • 1. Evaluation of chemoprevention of oral cancer with Spirulina fusiformis.
    Mathew B; Sankaranarayanan R; Nair PP; Varghese C; Somanathan T; Amma BP; Amma NS; Nair MK
    Nutr Cancer; 1995; 24(2):197-202. PubMed ID: 8584455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment.
    Sankaranarayanan R; Mathew B; Varghese C; Sudhakaran PR; Menon V; Jayadeep A; Nair MK; Mathews C; Mahalingam TR; Balaram P; Nair PP
    Oral Oncol; 1997 Jul; 33(4):231-6. PubMed ID: 9307711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission of oral precancerous lesions of tobacco/areca nut chewers following administration of beta-carotene or vitamin A, and maintenance of the protective effect.
    Stich HF; Mathew B; Sankaranarayanan R; Nair MK
    Cancer Detect Prev; 1991; 15(2):93-8. PubMed ID: 2032261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer.
    Zaridze D; Evstifeeva T; Boyle P
    Ann Epidemiol; 1993 May; 3(3):225-34. PubMed ID: 8275193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemoprevention of oral cancer--clinical and experimental studies].
    Szumiło J; Podlodowska J; Podlodowski W; Starosławska E; Burdan F
    Pol Merkur Lekarski; 2012 Feb; 32(188):138-42. PubMed ID: 22590920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial.
    Armstrong WB; Kennedy AR; Wan XS; Taylor TH; Nguyen QA; Jensen J; Thompson W; Lagerberg W; Meyskens FL
    Clin Cancer Res; 2000 Dec; 6(12):4684-91. PubMed ID: 11156220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis.
    Lippman SM; Batsakis JG; Toth BB; Weber RS; Lee JJ; Martin JW; Hays GL; Goepfert H; Hong WK
    N Engl J Med; 1993 Jan; 328(1):15-20. PubMed ID: 8416267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission of precancerous lesions in the oral cavity of tobacco chewers and maintenance of the protective effect of beta-carotene or vitamin A.
    Stich HF; Mathew B; Sankaranarayanan R; Nair MK
    Am J Clin Nutr; 1991 Jan; 53(1 Suppl):298S-304S. PubMed ID: 1985402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral cancer prevention: the case for carotenoids and anti-oxidant nutrients.
    Garewal H; Meyskens F; Friedman S; Alberts D; Ramsey L
    Prev Med; 1993 Sep; 22(5):701-11. PubMed ID: 8234210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of proteolytic activities as intermediate marker endpoints in oral carcinogenesis.
    Manzone H; Billings PC; Cummings WN; Feldman R; Clark LC; Odell CS; Horan AM; Atiba JO; Meyskens FL; Kennedy AR
    Cancer Epidemiol Biomarkers Prev; 1995; 4(5):521-7. PubMed ID: 7549809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum antioxidant micronutrients and the risk of oral leukoplakia among Japanese.
    Nagao T; Ikeda N; Warnakulasuriya S; Fukano H; Yuasa H; Yano M; Miyazaki H; Ito Y
    Oral Oncol; 2000 Sep; 36(5):466-70. PubMed ID: 10964055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of oral cancer: beta-carotene and vitamin E in leukoplakia.
    Garewal H
    Eur J Cancer Prev; 1994 Mar; 3(2):101-7. PubMed ID: 8019381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening at a health fair to identify subjects for an oral leukoplakia chemoprevention trial.
    Clayman GL; Chamberlain RM; Lee JJ; Lippman SM; Hong WK
    J Cancer Educ; 1995; 10(2):88-90. PubMed ID: 7669540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentrations of micronutrients during a nine-month clinical trial of beta-carotene in women with precursor cervical cancer lesions.
    Palan PR; Chang CJ; Mikhail MS; Ho GY; Basu J; Romney SL
    Nutr Cancer; 1998; 30(1):46-52. PubMed ID: 9507512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China.
    Yuan JM; Ross RK; Chu XD; Gao YT; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):767-73. PubMed ID: 11440962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micronutrient concentrations in paired skin and plasma of patients with actinic keratoses: effect of prolonged retinol supplementation.
    Peng YM; Peng YS; Lin Y; Moon T; Baier M
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):145-50. PubMed ID: 8467249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of beta-carotene in prevention of oral cancer.
    Garewal HS
    Am J Clin Nutr; 1991 Jan; 53(1 Suppl):294S-297S. PubMed ID: 1985401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum micronutrients and the subsequent risk of oral and pharyngeal cancer.
    Zheng W; Blot WJ; Diamond EL; Norkus EP; Spate V; Morris JS; Comstock GW
    Cancer Res; 1993 Feb; 53(4):795-8. PubMed ID: 8428360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
    Goodman GE; Schaffer S; Omenn GS; Chen C; King I
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):518-26. PubMed ID: 12814997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of oral leukoplakia with a low-dose of beta-carotene and vitamin C supplements: a randomized controlled trial.
    Nagao T; Warnakulasuriya S; Nakamura T; Kato S; Yamamoto K; Fukano H; Suzuki K; Shimozato K; Hashimoto S
    Int J Cancer; 2015 Apr; 136(7):1708-17. PubMed ID: 25156040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.